<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00659724</url>
  </required_header>
  <id_info>
    <org_study_id>Gambro 1462</org_study_id>
    <nct_id>NCT00659724</nct_id>
  </id_info>
  <brief_title>Ease of Use and Blood Clotting for the Gambro Polyflux HD-C4 Big Dialyzer</brief_title>
  <official_title>The Gambro Polyflux HD-C4 Big Ease Of Use And Thrombogenicity Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Advanced Dialysis Center of Potomac</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Advanced Dialysis Center of Easton</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gambro Renal Products, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Baxter Healthcare Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect information on the ease of use and thrombogenicity of
      the Polyflux HD-C4 Big and Fresenius Optiflux 180NR or 200NR dialyzers under conditions of
      routine clinical use for hemodialysis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This ease of use study involves the use of FDA 510(k) cleared hemodialyzers and will have no
      impact on the patient's routine dialysis therapy. This study is aimed at obtaining feedback
      from the nursing and technical staff regarding the use and thrombogenicity of the Polyflux
      HD-C4 Big, and Fresenius Optiflux 180NR or 200NR dialyzers. The dialysis nursing staff will
      complete ease of use and thrombogenicity assessments following routine dialysis therapy. Any
      adverse events will be tracked for the study patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ease of Use: Priming Blood Side</measure>
    <time_frame>Priming at each treatment</time_frame>
    <description>For every study treatment/dialyzer, the nursing staff rated the ease of priming blood side as follows:
Very Easy:Air is easily removed without knocking or clamping procedures. Acceptable:Knocking and/or clamping required for efficient air removal. Difficult:Knocking and/or clamping and additional volume of saline or extended recirculation needed to remove air.
Very Difficult:Air could not be removed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ease of Use: Priming Dialysate Side</measure>
    <time_frame>Priming at each treatment</time_frame>
    <description>For every study treatment/dialyzer, the nursing staff rated the ease of priming dialysate side as follows:
Dialysate Side at 500 ml Priming Volume (check one):
Perfect: No air visible. Acceptable: Some air visible, but considered insignificant. Not Acceptable: Additional actions needed to sufficiently remove air.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dialyzer Assessment: Fiber Condition</measure>
    <time_frame>Each treatment: assessment of the condition of the dialyzer fibers after rinse-back</time_frame>
    <description>For every study treatment/dialyzer, the nursing staff rated the condition of the dialyzer fibers after rinse-back as follows:
Very Good:All fibers appear white. Good:Few fibers (less than 10) appear PINK / RED. (check one) Poor:Several fibers (more than 10) appear PINK / RED. (check one) Very Poor:Most fibers (more than 75%) appear PINK / RED. (check one)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dialyzer Assessment: Arterial Header Condition</measure>
    <time_frame>Each treatment: assessment of the condition of the arterial header after rinse-back</time_frame>
    <description>For every study treatment/dialyzer, the nursing staff rated the condition of the arterial header after rinse-back as follows:
Very Good:Surface as clean as expected. Good:Distinct red ring appears at the dialyzer wall. Poor:Significant appearance of clots, randomly distributed on the surface. Very Poor:Completely red and/or covered with clots.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dialyzer Assessment: Venous Header Condition</measure>
    <time_frame>Each treatment: the assessment of the condition of the venous header after rinse-back</time_frame>
    <description>For every study treatment/dialyzer, the nursing staff rated the condition of the venous header after rinse-back as follows:
Very Good:Surface as clean as expected. Good:Distinct red ring appears at the dialyzer wall. Poor:Significant appearance of clots, randomly distributed on the surface. Very Poor:Completely red and/or covered with clots.</description>
  </primary_outcome>
  <enrollment type="Actual">33</enrollment>
  <condition>Chronic Kidney Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Assessment of dialyzer ease of use and thrombogenicity assessments following routine
        dialysis therapy of 33 adult patients (18 years of age or older)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hemodialysis patients 18 years of age or older

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Advanced Dialysis Center of Easton</name>
      <address>
        <city>Easton</city>
        <state>Maryland</state>
        <zip>21601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Dialysis Center of Potomac</name>
      <address>
        <city>Arlington</city>
        <state>Virginia</state>
        <zip>22202-2714</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2008</study_first_submitted>
  <study_first_submitted_qc>April 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2008</study_first_posted>
  <results_first_submitted>March 7, 2011</results_first_submitted>
  <results_first_submitted_qc>May 27, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 27, 2011</results_first_posted>
  <last_update_submitted>April 4, 2017</last_update_submitted>
  <last_update_submitted_qc>April 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dialyzer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Hemodialysis Patients</title>
          <description>Hemodialysis patients 18 years of age or older receiving routine dialysis treatment for chronic renal failure.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Weeks 1-2: Assessment of 180NR or 200NR</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Weeks 3-4: Assessment of HD-C4 Big</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Hemodialysis Patients</title>
          <description>Hemodialysis patients 18 years of age or older receiving routine dialysis treatment for chronic renal failure.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="33"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.0" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>inches</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.6" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Ease of Use: Priming Blood Side</title>
        <description>For every study treatment/dialyzer, the nursing staff rated the ease of priming blood side as follows:
Very Easy:Air is easily removed without knocking or clamping procedures. Acceptable:Knocking and/or clamping required for efficient air removal. Difficult:Knocking and/or clamping and additional volume of saline or extended recirculation needed to remove air.
Very Difficult:Air could not be removed.</description>
        <time_frame>Priming at each treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Revaclear MAX</title>
          </group>
          <group group_id="O2">
            <title>Optiflux F180NR</title>
          </group>
          <group group_id="O3">
            <title>Optiflux F200NR</title>
          </group>
        </group_list>
        <measure>
          <title>Ease of Use: Priming Blood Side</title>
          <description>For every study treatment/dialyzer, the nursing staff rated the ease of priming blood side as follows:
Very Easy:Air is easily removed without knocking or clamping procedures. Acceptable:Knocking and/or clamping required for efficient air removal. Difficult:Knocking and/or clamping and additional volume of saline or extended recirculation needed to remove air.
Very Difficult:Air could not be removed.</description>
          <units>Number of Dialyzers</units>
          <param>Number</param>
          <units_analyzed>Dialyzers</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
                <count group_id="O3" value="33"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Dialyzers</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="219"/>
                <count group_id="O2" value="95"/>
                <count group_id="O3" value="97"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Very Easy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="139"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Acceptable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80"/>
                    <measurement group_id="O2" value="82"/>
                    <measurement group_id="O3" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ease of Use: Priming Dialysate Side</title>
        <description>For every study treatment/dialyzer, the nursing staff rated the ease of priming dialysate side as follows:
Dialysate Side at 500 ml Priming Volume (check one):
Perfect: No air visible. Acceptable: Some air visible, but considered insignificant. Not Acceptable: Additional actions needed to sufficiently remove air.</description>
        <time_frame>Priming at each treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Revaclear MAX</title>
          </group>
          <group group_id="O2">
            <title>Optiflux F180NR</title>
          </group>
          <group group_id="O3">
            <title>Optiflux F200NR</title>
          </group>
        </group_list>
        <measure>
          <title>Ease of Use: Priming Dialysate Side</title>
          <description>For every study treatment/dialyzer, the nursing staff rated the ease of priming dialysate side as follows:
Dialysate Side at 500 ml Priming Volume (check one):
Perfect: No air visible. Acceptable: Some air visible, but considered insignificant. Not Acceptable: Additional actions needed to sufficiently remove air.</description>
          <units>Number of Dialyzers</units>
          <param>Number</param>
          <units_analyzed>Dialyzers</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
                <count group_id="O3" value="33"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Dialyzers</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="220"/>
                <count group_id="O2" value="95"/>
                <count group_id="O3" value="97"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Perfect</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="131"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Acceptable</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89"/>
                    <measurement group_id="O2" value="91"/>
                    <measurement group_id="O3" value="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Dialyzer Assessment: Fiber Condition</title>
        <description>For every study treatment/dialyzer, the nursing staff rated the condition of the dialyzer fibers after rinse-back as follows:
Very Good:All fibers appear white. Good:Few fibers (less than 10) appear PINK / RED. (check one) Poor:Several fibers (more than 10) appear PINK / RED. (check one) Very Poor:Most fibers (more than 75%) appear PINK / RED. (check one)</description>
        <time_frame>Each treatment: assessment of the condition of the dialyzer fibers after rinse-back</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Revaclear MAX</title>
          </group>
          <group group_id="O2">
            <title>Optiflux F180NR</title>
          </group>
          <group group_id="O3">
            <title>Optiflux F200NR</title>
          </group>
        </group_list>
        <measure>
          <title>Dialyzer Assessment: Fiber Condition</title>
          <description>For every study treatment/dialyzer, the nursing staff rated the condition of the dialyzer fibers after rinse-back as follows:
Very Good:All fibers appear white. Good:Few fibers (less than 10) appear PINK / RED. (check one) Poor:Several fibers (more than 10) appear PINK / RED. (check one) Very Poor:Most fibers (more than 75%) appear PINK / RED. (check one)</description>
          <units>Number of Dialyzers</units>
          <param>Number</param>
          <units_analyzed>Dialyzers</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
                <count group_id="O3" value="33"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Dialyzers</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="218"/>
                <count group_id="O2" value="95"/>
                <count group_id="O3" value="97"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Very Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="126"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75"/>
                    <measurement group_id="O2" value="44"/>
                    <measurement group_id="O3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Poor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Very Poor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Dialyzer Assessment: Arterial Header Condition</title>
        <description>For every study treatment/dialyzer, the nursing staff rated the condition of the arterial header after rinse-back as follows:
Very Good:Surface as clean as expected. Good:Distinct red ring appears at the dialyzer wall. Poor:Significant appearance of clots, randomly distributed on the surface. Very Poor:Completely red and/or covered with clots.</description>
        <time_frame>Each treatment: assessment of the condition of the arterial header after rinse-back</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Revaclear MAX</title>
          </group>
          <group group_id="O2">
            <title>Optiflux F180NR</title>
          </group>
          <group group_id="O3">
            <title>Optiflux F200NR</title>
          </group>
        </group_list>
        <measure>
          <title>Dialyzer Assessment: Arterial Header Condition</title>
          <description>For every study treatment/dialyzer, the nursing staff rated the condition of the arterial header after rinse-back as follows:
Very Good:Surface as clean as expected. Good:Distinct red ring appears at the dialyzer wall. Poor:Significant appearance of clots, randomly distributed on the surface. Very Poor:Completely red and/or covered with clots.</description>
          <units>Number of Dialyzers</units>
          <param>Number</param>
          <units_analyzed>Dialyzers</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
                <count group_id="O3" value="33"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Dialyzers</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="218"/>
                <count group_id="O2" value="95"/>
                <count group_id="O3" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Very Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="155"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                    <measurement group_id="O2" value="66"/>
                    <measurement group_id="O3" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Poor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Very Poor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Dialyzer Assessment: Venous Header Condition</title>
        <description>For every study treatment/dialyzer, the nursing staff rated the condition of the venous header after rinse-back as follows:
Very Good:Surface as clean as expected. Good:Distinct red ring appears at the dialyzer wall. Poor:Significant appearance of clots, randomly distributed on the surface. Very Poor:Completely red and/or covered with clots.</description>
        <time_frame>Each treatment: the assessment of the condition of the venous header after rinse-back</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Revaclear MAX</title>
          </group>
          <group group_id="O2">
            <title>Optiflux F180NR</title>
          </group>
          <group group_id="O3">
            <title>Optiflux F200NR</title>
          </group>
        </group_list>
        <measure>
          <title>Dialyzer Assessment: Venous Header Condition</title>
          <description>For every study treatment/dialyzer, the nursing staff rated the condition of the venous header after rinse-back as follows:
Very Good:Surface as clean as expected. Good:Distinct red ring appears at the dialyzer wall. Poor:Significant appearance of clots, randomly distributed on the surface. Very Poor:Completely red and/or covered with clots.</description>
          <units>Number of Dialyzers</units>
          <param>Number</param>
          <units_analyzed>Dialyzers</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
                <count group_id="O3" value="33"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Dialyzers</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="217"/>
                <count group_id="O2" value="94"/>
                <count group_id="O3" value="97"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Very Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Good</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="140"/>
                    <measurement group_id="O2" value="31"/>
                    <measurement group_id="O3" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Poor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="52"/>
                    <measurement group_id="O3" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Very Poor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Hemodialysis Patients</title>
          <description>Hemodialysis patients 18 years of age or older receiving routine dialysis treatment for chronic renal failure.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jeffrey R. Shideman PhD</name_or_title>
      <organization>Gambro Renal Products, Inc.</organization>
      <phone>952-835-4018</phone>
      <email>Jeff.Shideman@us.gambro.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

